stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Debt to equity
Bausch + Lomb Corporation's debt to equity at the end of the quarter to 30 September 2026 was 0.8×, up 0.0× from fiscal 2025 (0.8×). Over the past ten years it has ranged from 0.0× (fiscal 2021) to 0.8× (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.8× | 6.63% |
| FY2024 | 0.7× | 10.91% |
| FY2023 | 0.7× | 92.13% |
| FY2022 | 0.3× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.8× | (1.41%) |
| Jun 2026 | 0.8× | 1.02% |
| Mar 2026 | 0.8× | 0.80% |
| Dec 2025 | 0.8× | 2.38% |
| 20 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ALGN Align Technology, Inc. compare | 0.0× |
| MMED MiniMed Group, Inc. compare | 0.0× |
| RGEN Repligen Corporation compare | 0.3× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| MMSI Merit Medical Systems, Inc. compare | 0.4× |
| ATR AptarGroup, Inc. compare | 0.5× |
| AVTR Avantor, Inc. compare | 0.6× |
| BLCO Bausch + Lomb Corporation | 0.8× |
| TFX Teleflex Incorporated compare | 1.0× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement